Cardiac Biomarker Change at 1 Year After Tafamidis Treatment and Clinical Outcomes in Patients With Transthyretin Amyloid Cardiomyopathy.

Cardiac Biomarker Change at 1 Year After Tafamidis Treatment and Clinical Outcomes in Patients With Transthyretin Amyloid Cardiomyopathy.

Fuente:Journal of The American Heart Association

Extracto: Deterioration in cardiac biomarkers during the first year after tafamidis treatment predicted a worse prognosis, suggesting the utility of serial assessment of cardiac biomarkers for monitoring the therapeutic response to tafamidis in patients with wild-type transthyretin amyloid cardiomyopathy.

Claves:B‐type natriuretic peptide, high‐sensitivity cardiac troponin T, tafamidis, wild‐type transthyretin amyloid cardiomyopathy

Cita:J Am Heart Assoc 2024 May 21; 13 (10) : e034518.

Autor/es:Kuyama, Naoto (a)
Takashio, Seiji (b)

institución:(a) Department of Cardiovascular Medicine, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan.
(b) Department of Cardiovascular Medicine, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan.

Formato:Informe impreso

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1161/JAHA.124.034518

Dynamic Mechanism of Cerebral Venous Disruption: Longitudinal Evidence From a Community-Based Cohort.

Fuente:Journal of The American Heart Association

Tipo de trabajo:Estudio de cohortes

Extracto: Our findings posed the dynamic pattern of brain parenchymal lesions related to DMVs injury, shedding light on the interactions and chronological roles of various pathological mechanisms.

Claves:brain atrophy, deep medullary veins, longitudinal study, neurodegenerative disease, white matter microstructure

Cita:J Am Heart Assoc 2024 May 21; 13 (10) : e034145.

Autor/es:Liu, Zi-Yue (a)
Wang, Pei (b)

institución:(a) Department of Neurology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
(b) Department of Neurology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.

Formato:Informe impreso

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1161/JAHA.123.034145

ZOom Delivered Intervention Against Cognitive decline (ZODIAC) COVID-19 pandemic adaptations to the Post-Ischaemic Stroke Cardiovascular Exercise Study (PISCES)

ZOom Delivered Intervention Against Cognitive decline (ZODIAC) COVID-19 pandemic adaptations to the Post-Ischaemic Stroke Cardiovascular Exercise Study (PISCES)

Fuente:Trials

Tipo de trabajo:Estudio aleatorizado y controlado

Extracto: TRIAL REGISTRATION: Prospectively ACTRN12616000942459. Registered on July 2016.

Claves:Brain volume, Cognition, Dementia, Exercise training, Ischaemic stroke, Physical activity, Telerehabilitation

Cita:Trials 2024 May 18; 25 (1) : 329.

Autor/es:Brodtmann, Amy (a)
Billett, Alex (b)

institución:(a) Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, VIC, Australia. amy.brodtmann@monash.edu.
(b) The Florey, Melbourne, VIC, Australia. amy.brodtmann@monash.edu.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s13063-024-08154-1

Homozygous EPRS1 missense variant causing hypomyelinating leukodystrophy-15 alters variant-distal mRNA m(6)A site accessibility.

Homozygous EPRS1 missense variant causing hypomyelinating leukodystrophy-15 alters variant-distal mRNA m(6)A site accessibility.

Fuente:Nature Communications

Extracto: These results reveal a new RNA-dependent etiologic mechanism by which SNVs can influence gene expression and disease, consequently generating opportunities for personalized, RNA-based therapeutics targeting these disorders.

Cita:Nat Commun 2024 May 20; 15 (1) : 4284.

Autor/es:Khan, Debjit (a)
Ramachandiran, Iyappan (b)

institución:(a) Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Lerner Research Institute, Cleveland, OH, USA.
(b) Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Lerner Research Institute, Cleveland, OH, USA.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1038/s41467-024-48549-x

Genetic associations between Rapid Eye Movement (REM) sleep behavior disorder and cardiovascular diseases.

Genetic associations between Rapid Eye Movement (REM) sleep behavior disorder and cardiovascular diseases.

Fuente:Plos One

Extracto: Our study highlighted the potential associations between RBD and cardiovascular diseases at genetic level, including HF and MI. More studies were required to clarify the biological mechanisms involved the associations.

Cita:PLoS One 2024; 19 (5) : e0301112.

Autor/es:Xu, Pengfei (a)
Wei, Yitong (b)

institución:(a) Department of Neurosurgery, Nanyang Central Hospital, Nanyang, Henan, China.
(b) Department of Neurosurgery, Nanyang Central Hospital, Nanyang, Henan, China.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:EE.UU.

Sitio web:http://dx.doi.org/10.1371/journal.pone.0301112

Deregulated miR-146a-3p alleviates disease progression in atherosclerosis through inactivating NF-?B: An experimental study.

Fuente:Medicine

Extracto: miR-146a-3p might inhibit inflammation by targeting NF-κB in AS progression, and miR-146a-3p/ NF-κB might provide novel biomarkers and therapeutic targets for the prevention of AS and related vascular events.

Cita:Medicine (Baltimore) 2024 May 17; 103 (20) : e38061.

Autor/es:Tao, Taotao (a)
Chen, Linkao (b)

institución:Tao, Taotao (a)
Chen, Linkao (b)

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe impreso

Idioma:Inglés

País de fuente:EE.UU.

Sitio web:http://dx.doi.org/10.1097/MD.0000000000038061

Paroxysmal sympathetic hyperexcitability after brain injury: A clinical analysis of case series.

Fuente:Medicine

Extracto: The etiology of PSH is complex. TBI may be the most common cause of PSH. Non-TBI may also be an important cause of PSH. Therefore, early identification, prevention and diagnosis are helpful for determining the prognosis and outcome of the disease.

Cita:Medicine (Baltimore) 2024 May 17; 103 (20) : e35375.

Autor/es:Li, Xingru (a)
Yang, Xinchen (b)

institución:(a) Department of Neurosurgery, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, China.
(b) Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe impreso

Idioma:Inglés

País de fuente:EE.UU.

Sitio web:http://dx.doi.org/10.1097/MD.0000000000035375

The effect of amantadine treatment on neurological outcome and mortality in mechanically ventilated severe head trauma patients in intensive care unit.

Fuente:Medicine

Extracto: However, further research is needed to investigate this topic.

Cita:Medicine (Baltimore) 2024 May 17; 103 (20) : e38172.

Autor/es:Öner, Özlem (a)
Hanci, Volkan (b)

institución:(a) Anesthesiologist and Intensivist Neuroscience, Dokuz Eylül University Faculty of Medicine Department of Anesthesiology and Reanimation, Subdivision of Critical Care Medicine, İzmir, Turkey.
(b) Anesthesiologist and Intensivist, Dokuz Eylül University Faculty of Medicine Department of Anesthesiology and Reanimation, Subdivision of Critical Care Medicine, İzmir, Turkey.

Conflicto:The authors have no funding and conflicts of interest to disclose.

Formato:Informe impreso

Idioma:Inglés

País de fuente:EE.UU.

Sitio web:http://dx.doi.org/10.1097/MD.0000000000038172

Glycolic acid and D-lactate-putative products of DJ-1-restore neurodegeneration in FUS - and SOD1-ALS.

Fuente:Life Science Alliance

Extracto: Whereas these data point towards the necessity of individualized (gene-) specific therapy stratification, it also suggests common therapeutic targets across different neurodegenerative diseases characterized by mitochondrial depolarization.

Cita:Life Sci Alliance 2024 Aug; 7 (8)

Autor/es:Pal, Arun (a)
Grossmann, Dajana (b)

institución:(a) Division for Neurodegenerative Diseases, Department of Neurology, Technische Universität Dresden, Dresden, Germany.
(b) Dresden High Magnetic Field Laboratory (HLD-EMFL), Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.

Conflicto:A Hermann has received personal fees and non-financial support from Biogen and Desitin during the conduct of the study outside the submitted work. R Günther has received honoraria from Biogen as an advisory board member and for lectures and as a consultant and advisory board member from Hoffmann-La Roche. He also received travel expenses and research support from Biogen. F... F Pan-Montojo has a patent on the use of glycolic acid and D-lactate as neuroprotective treatment for neurodegenerative disease. In addition, F Pan-Montojo is the CEO and CSO of Neurevo GmbH, a biotech company developing glycolic acid and D-lactate as neuroprotective treatments for several neurological diseases. INSTITUTIONAL REVIEW BOARD STATEMENT: The performed procedures were in accordance with the Declaration of Helsinki (WMA, 1964) and approved by the Ethical Committee of the Technische Universität Dresden, Germany (EK 393122012 and EK 45022009). INFORMED CONSENT STATEMENT: Written informed consent was obtained from all participants including for publication of any research results.

Formato:Informe virtual

Idioma:Inglés

País de fuente:EE.UU.

Sitio web:http://dx.doi.org/10.26508/lsa.202302535

Integrated bioinformatics analysis for exploring potential biomarkers related to Parkinson's disease progression.

Fuente:Bmc Medical Genomics

Extracto: We identified PD-related molecular markers and ceRNA regulatory networks, providing new directions for PD diagnosis and treatment.

Claves:Dopaminergic neurons, Hub genes, Parkinson, ceRNA network, circRNA, s disease

Cita:BMC Med Genomics 2024 May 17; 17 (1) : 133.

Autor/es:Huang, Zhenchao (a)
Song, En'peng (b)

institución:(a) Department of Neurosurgery, Lingnan Hospital, Branch of The Third Affiliated Hospital of Sun Yat-Sen University, No 2693, Kaichuang Avenue, Huangpu District, Guangzhou, 510530, Guangdong, China. hzhench3@mail.sysu.edu.cn.
(b) Department of Neurosurgery, Lingnan Hospital, Branch of The Third Affiliated Hospital of Sun Yat-Sen University, No 2693, Kaichuang Avenue, Huangpu District, Guangzhou, 510530, Guangdong, China.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s12920-024-01885-9

Genome-wide identification, classification and expression analysis of the heat shock transcription factor family in Garlic (Allium sativum L.).

Fuente:Bmc Plant Biology

Extracto: This study is the first to unravel and analyze the AsHSF genes in garlic, thereby opening up new avenues for understanding their functions. The insights gained from this research provide a valuable resource for future investigations, particularly in the functional analysis of AsHSF genes.

Claves:Expression profile, Garlic, Genome-wide, Heat shock transcription factors (HSFs)

Cita:BMC Plant Biol 2024 May 18; 24 (1) : 421.

Autor/es:Hao, Xiaomeng (a)
He, Shutao (b)

institución:(a) Institute of Neurobiology, Jining Medical University, Jining, China.
(b) Institute of Biotechnology and Health, Beijing Academy of Science and Technology, Beijing, China. heshutao@bjast.ac.cn.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s12870-024-05018-3

Protocolized reduction of non-resuscitation fluids versus usual care in septic shock patients (REDUSE)

Fuente:Critical Care (london, England)

Tipo de trabajo:Estudio multicéntrico

Extracto: Protocolized reduction of non-resuscitation fluids in patients with septic shock resulted in a large decrease in fluid administration compared with usual care. A trial using this design to test if reducing non-resuscitation fluids improves outcomes is feasible. TRIAL REGISTRATION: Clinicaltrials.gov, NCT05249088, 18 February 2022. https://clinicaltrials.gov/ct2/show/NCT05249088.

Claves:Feasibility, Fluid therapy, Non-resuscitation fluids, Randomized controlled trial, Septic shock

Cita:Crit Care 2024 May 17; 28 (1) : 166.

Autor/es:Lindén, Anja (a)
Spångfors, M (b)

institución:(a) Anesthesiology and Intensive Care, Department of Clinical Sciences Lund, Lund University, Lund, Sweden. anja.linden.icu@gmail.com.
(b) Department of Anesthesiology and Intensive Care, Helsingborg Hospital, Charlotte Yhléns Gata 10, 252 23, Helsingborg, Sweden. anja.linden.icu@gmail.com.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s13054-024-04952-w

A longer time to relapse is associated with a larger increase in differences between paired primary and recurrent IDH wild-type glioblastomas at both the transcriptomic and genomic levels.

Fuente:Acta Neuropathologica Communications

Extracto: Our findings provide new insights into the molecular understanding of GBM progression at recurrence and potential targets for therapeutic treatments.

Claves:Glioblastomas, Patient-matched longitudinal analysis, Prognostic model, Progression-free survival, Time to relapse

Cita:Acta Neuropathol Commun 2024 May 18; 12 (1) : 77.

Autor/es:Ho, Wei-Min (a)
Chen, Chia-Ying (b)

institución:(a) Genomics Research Center, Academia Sinica, Taipei, Taiwan.
(b) Ph.D. Program in Translational Medicine, National Taiwan University and Academia Sinica, Taipei, Taiwan.

Conflicto:The authors declare that they do not have any competing interests.

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s40478-024-01790-3

Predictive value of Cmmi-MHR combined with thromboelastography parameters in acute cerebral infarction.

Fuente:Bmc Medical Imaging

Extracto: The conclusion indicates that the combination of Cmmi-MHR and thromboelastography parameters provides a new perspective and method for the diagnosis and treatment of cerebral infarction, and provides important support for personalized treatment and management of cerebral infarction.

Claves:Acute cerebral infarction, High frame rate imaging, Monocyte to high-density lipoprotein ratio, Predictive value

Cita:BMC Med Imaging 2024 May 18; 24 (1) : 115.

Autor/es:Rao, Zhongxian (a)
Tan, Wei (b)

institución:(a) Geriatric Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei, 430065, China.
(b) General Medicine, Geriatric Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei, 430065, China.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s12880-024-01299-0

Blood biomarkers of neurodegeneration associate differently with amyloid deposition, medial temporal atrophy, and cerebrovascular changes in APOE ?4-enriched cognitively unimpaired elderly.

Fuente:Alzheimer's Research & Therapy

Extracto: Only increased serum NfL concentrations and decreased hippocampal volume was observed in cognitively unimpaired APOEε4 homozygotes compared to non-carriers. In the whole population the concentrations of blood biomarkers were affected in distinct ways by different pathologies.

Claves:Alzheimer’s disease, Blood biomarkers, PET imaging

Cita:Alzheimers Res Ther 2024 May 18; 16 (1) : 112.

Autor/es:Koivumäki, Mikko (a)
Ekblad, Laura (b)

institución:(a) Turku PET Centre, Turku University Hospital, University of Turku, Turku, Finland. mikkkoi@utu.fi.
(b) Turku PET Centre, Turku University Hospital, University of Turku, Turku, Finland.

Conflicto:HZ has served at scientific advisory boards and/or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZPath, Annexon, Apellis, Artery Therapeutics, AZTherapies, CogRx, Denali, Eisai, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure, Biogen, and Roche, and... is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). KB has served as a consultant and at advisory boards for Acumen, ALZPath, BioArctic, Biogen, Eisai, Lilly, Moleac Pte. Ltd, Novartis, Ono Pharma, Prothena, Roche Diagnostics, and Siemens Healthineers; has served at data monitoring committees for Julius Clinical and Novartis; has given lectures, produced educational materials and participated in educational programs for AC Immune, Biogen, Celdara Medical, Eisai and Roche Diagnostics; and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program, outside the work presented in this paper.

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s13195-024-01477-w

Prognostic factors and overall survival of breast cancer in Benin: a hospital-based study.

Fuente:Bmc Women's Health

Extracto: Breast cancer in Beninese is predominant in young adults and is often diagnosed at a late stage. The survival of breast cancer patients in Benin can be improved by enhancing early diagnosis and multidisciplinary management.

Claves:Benin, Breast cancer, Prognostic factors, Sub-saharan africa, Survival

Cita:BMC Womens Health 2024 May 18; 24 (1) : 295.

Autor/es:Gnangnon, Freddy Houéhanou Rodrigue (a)
Parenté, Alexis (b)

institución:(a) Laboratory of Epidemiology of Chronic and Neurological Diseases, Lemacen, Cotonou, Benin. fredgnang@yahoo.fr.
(b) Department of Visceral Surgery, National Teaching Hospital-Hubert Koutoukou Maga, CNHU-HKM, Cotonou, Benin. fredgnang@yahoo.fr.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s12905-024-03114-y

Chanwuyi Lifestyle Medicine Program Improves Memory and Executive Functions of Older Adults With Mild Cognitive Impairment.

Fuente:American Journal of Alzheimer's Disease and Other Dementias

Extracto: This study provides preliminary evidence for the effects of the CLMP on improving memory, attention, and executive functions in MCI.

Claves:attention, executive functions, lifestyle intervention, memory, mild cognitive impairment, strategic memory training

Cita:Am J Alzheimers Dis Other Demen 2024 Jan-Dec; 39 : 15333175241255744.

Autor/es:Cheung, Mei-Chun (a)
Sze, Sophia L (b)

institución:(a) Department of Social Work, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China. RINGGOLD: 26451
(b) Research Center for Neuropsychological Well-Being, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China. RINGGOLD: 26451

Conflicto:Declaration of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Formato:Informe impreso

Idioma:Inglés

País de fuente:EE.UU.

Sitio web:http://dx.doi.org/10.1177/15333175241255744

Validation of a New Patient-Reported Outcome Measure of the Functional Impact of Essential Tremor on Activities of Daily Living.

Fuente:Tremor and Other Hyperkinetic Movements (new York, N.y.)

Tipo de trabajo:Guía

Extracto: TETRAS PRO is a valid and reliable scale that is influenced strongly by tremor severity, moderately by mood (depression), and minimally by coping skills. The MDC for TETRAS PRO is probably sufficient to detect clinically important change.

Claves:anxiety, coping skills, depression, essential tremor, patient-reported outcome measure

Cita:Tremor Other Hyperkinet Mov (N Y) 2024; 14 : 26.

Autor/es:Shih, Ludy C (a)
Stevenson, Michael T (b)

institución:(a) Beth Israel Deaconess Medical Center, Department of Neurology, Boston, MA 02215, US.
(b) Harvard Medical School, Boston, MA 02215, US.

Conflicto:LCS receives consulting fees from Medtronic, WCG Medavante, and Encora Therapeutics, receives honoraria from Wiley for editorial work, and research grant funding from Praxis Precision Medicines and NIH. MTS is supported by research funds from Praxis, Biogen, and NIH. SB has served as site PI for clinical research trials funded by Sage and AbbVie. AF has stock ownership in Inbrain... Pharma and has received payments as consultant and/or speaker from Abbvie, Abbott, Boston Scientific, Ceregate, Dompé Farmaceutici, Inbrain Neuroelectronics, Ipsen, Medtronic, Iota, Syneos Health, Merz. He has received research support from Abbvie, Boston Scientific, Medtronic, Praxis, ES and receives royalties from Springer. SHK receives consulting fees from Praxis, Sage, and Jazz. KEL is president of the International Essential Tremor Foundation. HM received consulting fees from Ipsen Pharma and receives research support from MODUS Outcomes LLC, TEVA Pharmaceuticals, SAGE Therapeutics, Bukwang Pharmaceuticals, Neurocrine Biosciences, CDHI Foundation. HAS received research support from Transposon, NINDS, Parkinson Study Group/UCB, Parkinson’s Foundation, MJFF, Jazz Pharmaceuticals, Intra-cellular Therapeutics and Barrow Neurological Foundation. HAS has also served as a consultant for Abbvie, Sage/Biogen, Praxis, KeifeRx, Fasikl and Jazz Pharmaceuticals. AWS reports grant support from the NIH R01 NS122943 as PI and R01 NS121120-01 as a Co-I. She reports past funding from Benign Essential Blepharospasm Research Foundation, Dystonia Coalition, Dystonia Medical Research Foundation, and National Organization for Rare Disorders. AWS has received consultant fees from Merz, Jazz, Fasikl, Encora and Acadia. She is the current Vice President for the Tremor Research Group and recent advisor for Supernus and Biogen-Sage. CS received grant funding from Teva Pharmaceuticals and the Parkinson Foundation. RJE receives consulting fees from Applied Therapeutics, ES Therapeutics, Neurocrine Biosciences, Encora, Fasikl, Jazz, and Sage; and serves on the International Essential Tremor Foundation Medical Advisory Board.

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.5334/tohm.886

Hyperkinetic and Hypokinetic Movement Disorders in SSPE

Fuente:Tremor and Other Hyperkinetic Movements (new York, N.y.)

Tipo de trabajo:Revisión sistemática

Extracto: SSPE is associated with diverse movement disorders, predominantly hyperkinetic. The prevalence of dystonia suggests basal ganglia dysfunction.

Claves:Basal ganglion, Dystonia, Measles, Movement Disorders

Cita:Tremor Other Hyperkinet Mov (N Y) 2024; 14 : 27.

Autor/es:Garg, Ravindra Kumar (a)
Pandey, Shweta (b)

institución:(a) Department of Neurology, King George's Medical University, Lucknow, India.
(b) Department of Neurology, King George's Medical University, Lucknow, India.

Conflicto:The authors have no competing interests to declare.

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.5334/tohm.875

A large and diverse brain organoid dataset of 1,400 cross-laboratory images of 64 trackable brain organoids.

Fuente:Scientific Data

Extracto: Therefore, this dataset allows to perform differentiated analyses to delineate strengths, weaknesses, and generalizability of automated organoid analysis pipelines as well as analysis of clone diversity and similarity.

Cita:Sci Data 2024 May 20; 11 (1) : 514.

Autor/es:Schröter, Julian (a)
Deininger, Luca (b)

institución:(a) Division of Pediatric Epileptology, Center for Pediatrics and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.
(b) Division of Pediatric Neurology and Metabolic Medicine, Department I, Center for Pediatric and Adolescent Medicine, Medical Faculty Heidelberg, University Hospital Heidelberg, Heidelberg, Germany.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1038/s41597-024-03330-z